Not Yet Classified

This recall has not yet been classified by risk level.

NumbSkin Pain Relief Cream Recalled by SeeNext Venture Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning (Recall Alert)

Date: March 18, 2020
Company: SeeNext Venture
Status: Ongoing
Source: CPSC

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Consumers should immediately store the pain relief cream in a safe location out of reach of children and contact SeeNext Venture for instructions on how to dispose or return it and to receive a free replacement similar product with a child-resistant cap. Amazon is contacting all known purchasers directly. Options: Replace

Affected Products

This recall involves NumbSkin pain relief cream with 5% lidocaine. The topical anesthetic cream was sold in 30 grams in a white with blue tube. NumbSkin is printed on the tube. Lot 9238 and a date code of 10/2019 through 09/2020 in a MM/YYYY format is embossed on the tub's thin end. Batch number 9238 is printed on the product packaging.

Why Was This Recalled?

The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving cream contains lidocaine, posing a risk of poisoning to young children if they put it on their skin or ingest it.

Where Was This Sold?

Distribution information not available.

About SeeNext Venture

SeeNext Venture has 1 total recall tracked by RecallDetector.

Related Recalls

Data sourced from the CPSC. Last updated March 26, 2026. View original report